WIKIFARMER
9.2.2023 08:34:50 CET | Business Wire | Press release
Wikifarmer, the direct farmer-to-business agricultural marketplace—aptly described as the “Wikipedia of farming”—has raised a €5M in a late seed round, led by Point Nine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005806/en/
Ilias Sousis and Petros Sagkos, founders of Wikifarmer (Photo: Business Wire)
The Athens-based startup will use the funding for pan-European expansion and to enrich its knowledge library. It will further enhance its platform to fully digitize transactions end-to-end, and offer innovative financial and logistic solutions to both buyers and sellers.
As a whole, Wikifarmer is an ecosystem that supports farmers from start to finish. It enables them to learn, sell and make their business lives easier.
On the supply side, farmers receive the value they deserve: they produce more efficiently, sell directly, and enjoy an increase in their profitability by up to 300%. Higher profitability for farmers means a higher capacity for investments in production, higher employment, and higher sustainability.
On the demand side, Wikifarmer acts as a purchasing assistant for B2B buyers, such as wholesalers, larger hotels, restaurant chains, small and medium size retailers, or food processing units. It provides hassle-free sourcing of agricultural products, helps parties to negotiate prices efficiently online, offers logistics support, ensures security and transaction transparency and facilitates 60 - 90 days of credit.
What’s next?
“Our vision is to restructure the supply chain, digitize processes, and ultimately generate more value for all parties involved. Our mission is to become Europe’s leading B2B trading platform within the next two years. This round of funding will allow us to accelerate our product development in order to offer 360° coverage of agricultural transactions” explains Wikifarmer’s Co-Founder and CEO, Ilias Sousis.
Petros Sagos, Co-Founder and Chief Science Officer, concludes: “Above all, we hope this funding will enable us to turn our long-standing vision into reality: democratize agriculture and support farmers in modernizing their techniques, selling their products, and earning the value they deserve"
Point 9 is a B2B SaaS and B2B marketplace-specialized VC firm with investments such as Revolut, Delivery Hero, Docplanner, and cargo.one and one of the highest “seed-to-winner” rates in the industry. The round was complemented by relevant Business Angels (the founders of cargo.one, Nikos Moraitakis - co-founder and CEO of Workable, Przemyslaw Budkowski - CEO of Merxu, Cihan Aksakal - founder of Zenjob, Louis Pfizner - founder of Caya.com and Treatwell), as well as prior investors including leading Greek VC Metavallon, plus angels such as Sophia Bendz.
“B2B marketplaces, which bring mostly analog industries online, are a core area of focus for us at Point Nine. We have been partnering with one or two new B2B marketplaces every year, for the last 7 years, including REKKI (restaurants) in 2016, Container xChange (containers) and Laserhub (metal parts) in 2017, cargo.one (air cargo) in 2018, MerXu (industrial products) in 2019, Rooser (seafood) in 2020, and now Wikifarmer. The food industry is gigantic and presents its own challenges, but we’ve been impressed by Ilias’s and Peter’s unique approach to digitizing the industry. We’re excited to play a small role in their long-term success” says Louis Coppey, partner at Point Nine.
The Industry and Context
In addition to being the no.1 employer[1] in the world, the agrifood industry generates a total turnover of 1.2 trillion Euros in Europe alone[2] and has a major impact on the everyday life of every single person on the planet. Yet, a significant number of farmers still lack access to modern agricultural best practices, and it remains one of the least digitized sectors. The pandemic, the outbreak of the war in Ukraine, along with climate change, population growth predictions, and the scarcity of natural resources have all had a major impact on the supply chain, and eventually, the food on our plates. The past few years have been challenging for the agrifood sector, placing increased demands on food security and sustainable solutions. Wikifarmer responds to the need for new technologies and ideas that have the potential to reshape agriculture, and this is reflected in the startup’s growth.
The Product
Wikifarmer is an ecosystem of content and agricultural products that promote a fairer, more transparent and sustainable value chain in the food industry. With Wikifarmer, farmers can sell their output to multiple buyers, achieve a better price, monitor fair market prices, and access international markets. The startup also offers instant payments to farmers and helps them with logistics and financing, allowing them to increase their profitability on the Wikifarmer marketplace. At the same time, it provides them with a wide collection of agricultural best practices and how-to guides, which have been translated into 16 languages and are freely accessible on the Wikifarmer Library.
On the platform, farmers can use the Wikifarmer library to upgrade their techniques, in order to improve the quality of their produce and boost their efficiency. Then, they can upload their products on the Wikifarmer Market and sell directly to buyers from all over the world.
The story behind the startup
Looking back to where everything started, the founding team is a metaphor for Wikifarmer's mission: matching digitization with agricultural science. CEO Ilias Sousis, a senior ex-Googler for 11 years, and Chief Science Officer Petros Sagos, an accomplished agronomist, have been best friends since primary school. "We started Wikifarmer because we thought things should be done differently" they explain.
Today, Wikifarmer is approaching 1m unique visitors per month. It has allowed thousands of businesses to slash costs by up to 30%, enabling farmers to sell their products without intermediaries, while growing their potential clientele, reducing waste, and tripling their profitability. The Wikifarmer library has been dubbed the “Wikipedia of Farming” by the United Nations and is now available in 16 languages.
About Wikifarmer
Wikifarmer is a global platform whose mission is to empower farmers by offering them education as well as direct access to commercial markets, so they can sell their products at fair prices.
About Point Nine
Founded in 2011, Point Nine is a European early-stage venture capital firm focused on B2B SaaS and B2B marketplace start-ups in Europe and North America. The firm is a seed investor in more than 150 companies in over 30 countries, including Algolia, Brainly, Chainalysis, Clio, Contentful, Delivery Hero, DocPlanner, Front, Loom, Mambu, Revolut, and Typeform, amongst others. Point Nine has one of the highest “seed-to-winner” rates in the industry.
About Metavallon
Metavallon VC specializes in pre-seed and seed-stage funding of disruptive technology companies. The firm invests in and works alongside ambitious entrepreneurs, helping them build transformational businesses across multiple stages, geographies and industries. Metavallon VC’s mission is to engage at a very early stage and invest in companies that will operate at the forefront of business and technology innovation.
[1] United Nations, 2017
[2] https://www.opendei.eu/agri-food-sector/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005806/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
